Results 181 to 190 of about 7,001,268 (342)

ACQUISITIONS [PDF]

Bulletin of the Detroit Museum of Art, 1915
openaire   +3 more sources

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Land Acquisition Amendment Act, 2000 (Zimbabwe) [PDF]

, 2001
Coldham, Simon
core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Sex-Based Differences in Disease Burden and Phenotype in CADASIL: A Multicenter Study of 368 Korean Patients. [PDF]

Neurol Genet
Kim JG, Choi JC, Kang CH, Oh JH, Lee JS, Kang JH, Byeon S, Lim JS, Kim BJ, Kim H, Suh CH, Heo SH, Woo HG, Nam HS, Lee BC, Yu KH, Oh MS, Lee M, Kim CK, Oh K, Kang SH, Lee KJ, Han JH, Kim YS, Kim HY, Kim HJ, Bae HJ, Han MK, Kang J, Kim BJ, Kim JY, Lee SH, Jung KH, Sohn SI, Hong JH, Park H, Kwon JH, Kim WJ, Shin DI, Yum KS, Chae HY, Sung SM, Seo SW, Kim JP, Jung JM, Lee K, Park TH, Park SS, Choi JK, Park MS, Kim JT, Choi KH, Cha JK, Kim DH, Yoon BA, Lee SJ, Kim JG, Kim DH, Kim DE, Gwak DS, Kim C, Lee SH, Lee J, Kwon DH, Kang K, Park KY, Jeong HB, Park CY, Cho YJ, Hong KS, Park HK.   +70 more
europepmc   +1 more source

Acquisitions: The Print Room

The Rijksmuseum Bulletin, 2011
openaire   +4 more sources

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Continuous bed motion versus step-and-shoot acquisition in LAFOV PET/CT: insights from multi-phantom and patient studies. [PDF]

EJNMMI Phys
Linder PM, Lan W, Calderón E, Rausch I, la Fougère C, Schmidt FP.   +5 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Development of a Protocol for Dynamic Gastric Emptying Scintigraphy. [PDF]

In Vivo
Tsuchitani T, Kitajima K, Nakamura T, Takahashi Y, Yamakado K.   +4 more
europepmc   +1 more source